Disc Medicine
IRON • NASDAQ
Disc Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John D. Quisel, with a market cap of $2.3B.
CEOJohn D. Quisel
Next Earnings
Upcoming earnings announcement for Disc Medicine
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.66
Revenue Estimate
$50.0K
Earnings History
Past 12 earnings reports for Disc Medicine
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$1.62Est: -$1.70 | +4.7% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$1.77Est: -$1.47 | -20.4% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$1.58Est: -$1.15 | -37.4% | - | — | 10-Q |
| May 7, 2025 | Q1 2025 | -$1.02Est: -$1.07 | +4.7% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.98Est: -$1.25 | +21.6% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.89Est: -$1.05 | +15.2% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.03Est: -$1.11 | +7.2% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.09Est: -$1.00 | -9.0% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.97Est: -$0.78 | -24.4% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.58Est: -$0.80 | +27.5% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.74Est: -$0.86 | +14.0% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$1.20Est: -$0.68 | -76.5% | - | — | — |